1. Home
  2. FULC vs LOCO Comparison

FULC vs LOCO Comparison

Compare FULC & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • LOCO
  • Stock Information
  • Founded
  • FULC 2015
  • LOCO 1980
  • Country
  • FULC United States
  • LOCO United States
  • Employees
  • FULC N/A
  • LOCO N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • LOCO Restaurants
  • Sector
  • FULC Health Care
  • LOCO Consumer Discretionary
  • Exchange
  • FULC Nasdaq
  • LOCO Nasdaq
  • Market Cap
  • FULC 372.2M
  • LOCO 323.7M
  • IPO Year
  • FULC 2019
  • LOCO 2014
  • Fundamental
  • Price
  • FULC $6.40
  • LOCO $10.31
  • Analyst Decision
  • FULC Buy
  • LOCO Buy
  • Analyst Count
  • FULC 8
  • LOCO 2
  • Target Price
  • FULC $7.13
  • LOCO $18.00
  • AVG Volume (30 Days)
  • FULC 420.8K
  • LOCO 168.1K
  • Earning Date
  • FULC 07-29-2025
  • LOCO 10-30-2025
  • Dividend Yield
  • FULC N/A
  • LOCO N/A
  • EPS Growth
  • FULC N/A
  • LOCO N/A
  • EPS
  • FULC N/A
  • LOCO 0.85
  • Revenue
  • FULC N/A
  • LOCO $479,690,000.00
  • Revenue This Year
  • FULC N/A
  • LOCO $6.29
  • Revenue Next Year
  • FULC N/A
  • LOCO $1.56
  • P/E Ratio
  • FULC N/A
  • LOCO $12.14
  • Revenue Growth
  • FULC 2752.05
  • LOCO 1.85
  • 52 Week Low
  • FULC $2.32
  • LOCO $8.29
  • 52 Week High
  • FULC $9.30
  • LOCO $13.99
  • Technical
  • Relative Strength Index (RSI)
  • FULC 44.51
  • LOCO 44.17
  • Support Level
  • FULC $6.36
  • LOCO $10.18
  • Resistance Level
  • FULC $6.75
  • LOCO $10.81
  • Average True Range (ATR)
  • FULC 0.30
  • LOCO 0.24
  • MACD
  • FULC 0.01
  • LOCO -0.01
  • Stochastic Oscillator
  • FULC 19.59
  • LOCO 21.48

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.

Share on Social Networks: